These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22454343)

  • 1. HIV-1 resistance to antiretroviral agents: relevance to mothers and infants in the breastfeeding setting.
    McConnell MS; Palumbo P
    Adv Exp Med Biol; 2012; 743():81-8. PubMed ID: 22454343
    [No Abstract]   [Full Text] [Related]  

  • 2. Breastfeeding and transmission of HIV-1: epidemiology and global magnitude.
    Fowler MG; Kourtis AP; Aizire J; Onyango-Makumbi C; Bulterys M
    Adv Exp Med Biol; 2012; 743():3-25. PubMed ID: 22454338
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of vertical transmission of HIV-1 in resource-limited settings.
    Coutsoudis A; Kwaan L; Thomson M
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1163-75. PubMed ID: 20954881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral drugs during breastfeeding for the prevention of postnatal transmission of HIV-1.
    Kourtis AP; de Vincenzi I; Jamieson DJ; Bulterys M
    Adv Exp Med Biol; 2012; 743():173-83. PubMed ID: 22454349
    [No Abstract]   [Full Text] [Related]  

  • 5. Breastfeeding among HIV-1 infected women: maternal health outcomes and social repercussions.
    Stringer E; Shearer K
    Adv Exp Med Biol; 2012; 743():39-49. PubMed ID: 22454340
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment of drug-resistant HIV-1 in latent reservoirs.
    Dahl V; Palmer S
    J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    Coovadia H
    N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
    [No Abstract]   [Full Text] [Related]  

  • 8. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ; Nesheim S
    Clin Perinatol; 2010 Dec; 37(4):825-42, x. PubMed ID: 21078453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of HIV infection in the breastfed infant.
    Ou CY; Fiscus S; Ellenberger D; Parekh B; Korhonen C; Nkengasong J; Bulterys M
    Adv Exp Med Biol; 2012; 743():51-65. PubMed ID: 22454341
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral drugs to prevent breastfeeding HIV transmission.
    Mofenson LM
    Antivir Ther; 2010; 15(4):537-53. PubMed ID: 20587847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of HIV transmission through breastfeeding and pediatric HIV infection.
    Van Rompay KK; Jayashankar K
    Adv Exp Med Biol; 2012; 743():89-108. PubMed ID: 22454344
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
    Kazennova EV
    Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of breastfeeding in the face of HIV-1 infection: science and policy.
    Bulterys M; Kourtis AP
    Adv Exp Med Biol; 2012; 743():301-4. PubMed ID: 22454359
    [No Abstract]   [Full Text] [Related]  

  • 16. The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?
    Fowler MG; Mofenson L; McConnell M
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):308-11. PubMed ID: 14600577
    [No Abstract]   [Full Text] [Related]  

  • 17. [HIV, breast feeding and antiretroviral agents].
    Engebretsen IM; Tylleskär T
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):520-2. PubMed ID: 20224625
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?
    Bulterys M; Wilfert CM
    AIDS; 2009 Nov; 23(18):2473-7. PubMed ID: 19838097
    [No Abstract]   [Full Text] [Related]  

  • 20. Limited risk of drug resistance after discontinuation of antiretroviral prophylaxis for the prevention of breastfeeding transmission of HIV.
    Palombi L; Luhanga R; Galluzzo C; Andreotti M; Liotta G; Ceffa S; Haswell J; Marazzi MC; Vella S; Giuliano M
    J Acquir Immune Defic Syndr; 2011 Aug; 57(4):301-4. PubMed ID: 21546847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.